Intelliject, Inc. Company Profile
Intelliject is a specialty pharmaceutical company dedicated to developing combination drug/device products that empower patients to control and gain freedom from their medical conditions. Each Intelliject product in development combines an established drug, an innovative delivery platform and a supporting dossier intended to show superiority, patient preference and cost effectiveness data.
News Articles
Intelliject gets $15m debt injection for pipeline
The private speciality pharmaceutical company Intelliject has agreed a $15 million debt facility with Hercules Technology Growth Capital to fund the acceleration of its key pipeline products. The new...
Intelliject, Inc. announces $15 million debt financing to accelerate targeted pipeline development
Intelliject, Inc., a specialty pharmaceutical company pioneering the next generation of drug/device combination products, today announced that it has entered into a $15 million de...
Specialty pharmaceutical company Intelliject has received the US Food and Drug Administration (FDA) approval for its Auvi-Q (epinephrine injection, USP) used in the emergency treatment of life-threate...
Intelliject, Inc. Receives FDA Approval for Auvi-Q
Intelliject, Inc. announced that the U.S. Food and Drug Administration (FDA) approved Auvi-Q™ (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in peopl...
FDA approves Intelliject's Auvi-Q for anaphylaxis
Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are...
Intelliject, Inc. Receives FDA Approval for Auvi-Q™ (epinephrine injection, USP)
Intelliject, Inc. announced that the U.S. Food and Drug Administration (FDA) approved Auvi-Q™ (epinephrine injection, USP) for the emergency treatment of life-threatening allerg...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Intelliject is a specialty pharmaceutical company dedicated to developing combination drug/device products that empower patients to control and gain freedom from their medical conditions. Each Intelli...
More Information about "Intelliject, Inc." on BioPortfolio
We have published hundreds of Intelliject, Inc. news stories on BioPortfolio along with dozens of Intelliject, Inc. Clinical Trials and PubMed Articles about Intelliject, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intelliject, Inc. Companies in our database. You can also find out about relevant Intelliject, Inc. Drugs and Medications on this site too.
